What is Clinomic?
Clinomic, founded in 2019 and headquartered in Aachen, Germany, is a privately held MedTech company specializing in AI-driven solutions for intensive care medicine. The company's flagship platform, Mona, is designed to streamline patient data management, enhance clinical decision-making, and facilitate telemedicine consultations. In 2022, Clinomic expanded its operations by forming the Clinomic Group, which encompasses subsidiaries dedicated to telemedicine, data analytics, and the digital transformation of hospital operations. Clinomic's core mission is to elevate critical care delivery through technological innovation, aiming to improve patient outcomes and optimize healthcare workflows.
How much funding has Clinomic raised?
Clinomic has raised a total of $25.6M across 1 funding round:
Series B
$25.6M
Series B (2025): $25.6M with participation from DeepTech & Climate Fonds
Key Investors in Clinomic
DeepTech & Climate Fonds
DeepTech & Climate Fonds (DTCF) is a venture capital fund focused on long-term investments in early growth ventures across Germany and Europe, specializing in DeepTech and ClimateTech. They provide capital and strategic support to companies with significant development cycles and capital needs.
What's next for Clinomic?
The recent major strategic investment, contextualized within Clinomic's enterprise-level funding, suggests the company is poised for significant scaling and market penetration. This capital infusion will likely fuel further research and development of its AI-driven platform, Mona, and support the expansion of its Clinomic Group subsidiaries. Strategic utilization of this backing could enable Clinomic to solidify its position in the MedTech industry, particularly in enhancing critical care and telemedicine services. Future growth may involve broader adoption of its solutions in hospitals and healthcare systems, potentially leading to further strategic partnerships or market consolidation.
See full Clinomic company page
